2013 EACPT Congress Symposia: Health Therapies Assessment

-->

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications

Symposium on Health Therapies Assessment

The UK’s National Institute of Health and Clinical Excellence (NICE) has led the way internationally in development of Health Technology Assessment (HTA), setting thresholds for acceptable cost-effectiveness, identifying factors that may modify this threshold (e.g. orphan drugs). NICE focused on disease-area treatment with multiple technology appraisals but has subsequently developed more rapid single-technology appraisal to provide authoritative clinical guidelines, quality standards, and implementation tools. Other European HTA agencies are based on relative effectiveness assessment of listed pharmaceuticals (REAL) and provide additional approaches in evaluating drug utility.

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org